Coller Capital’s fund closes the first RMB denominated GP-led transaction with Legend Capital | Coller Capital

IMPORTANT NOTICE: We have recently been made aware of fraudulent WhatsApp groups and imitation websites appearing to look like Coller Capital and exploiting our brand. Take caution and read the full notice.

X
News

Coller Capital’s fund closes the first RMB denominated GP-led transaction with Legend Capital

Coller Capital’s RMB secondaries fund (“CCSRMB I”) was the sole lead of this proprietary sourced GP-led transaction. The transaction’s total size is approximately RMB 315m.

The investment comprises of six high quality healthcare assets, with strong and well-diversified product lines across four subsectors of the healthcare industry: digital health, medical services, medical devices, and diagnostic technology. The portfolio has a strong track record within the healthcare sector in China.

This is the third transaction between Coller Capital and Legend Capital and emphasises the long-standing relationship between the two firms.

“This is the first deal Coller Capital has delivered in the Chinese RMB secondaries market through our dedicated RMB fund,” said Peter Kim, Partner and Head of Asia at Coller Capital. “We are excited to be partnering again with Legend Capital, a fund manager with an impressive track record.”

“Coller Capital’s strong presence in China has enabled us to originate and execute this complex GP-led transaction. We look forward to continuing to work together with Legend capital on this new investment,” said Zhan Yang, General Manager of Coller Capital’s Beijing office.

“It is a great honor to cooperate with Coller to complete this transaction. We fully believe that through the sincere cooperation of both parties, we can achieve a win-win situation for both the new and existing investors of the selling fund, as well as the portfolio companies. Legend Capital is a pioneer of GP-led secondary transactions in China. Since 2020, Legend Capital has completed multiple GP-led secondaries transactions in succession and made good progress. As the secondary market in China is becoming increasingly active, secondaries strategy has become a more and more important exit strategy of private equity funds, which also puts forward higher requirements for GP’s transaction ability. Legend Capital will continue to proactively create diversified exit opportunities and continue to bring excellent returns to investors.” said Jafar Wang, co-CIO of Legend Capital.

 

Related news & insights